1 of 1
Story summary
- European drug regulators endorsed acoziborole, a new sleeping sickness treatment that could improve access in Congo and other African nations.
- Acoziborole is taken as three pills in a single dose, unlike existing treatments requiring lengthy hospital stays.
- The World Health Organization (WHO) aims to halt the disease's spread by 2030.
- Sanofi will donate the drug, making it free for patients.
- Researchers caution that challenges remain in understanding transmission.
